Could less radiation be just as good for nasopharyngeal cancer?
NCT ID NCT07201337
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial is testing whether giving a lower dose of radiation to low-risk areas around the main tumor works as well as the standard higher dose for nasopharyngeal cancer. The study plans to enroll 700 people aged 18-70 with newly diagnosed, non-spreading cancer. The goal is to see if the reduced dose can control the cancer just as well while causing fewer side effects and improving quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- radiation therapy
- What this could lead to
- If successful, this could allow doctors to use lower radiation doses for some patients, reducing long-term side effects while still controlling the cancer.
- What could go wrong
- This is a large phase 3 trial, but it's testing a non-inferiority approach—meaning the reduced dose might not be as effective as the standard. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CANCINOMA (NPC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Cancer Hospital of Shantou University Medical College
RECRUITINGShantou, Guangdong, China
-
Affiliated Hospital of Guangdong Medical University
RECRUITINGZhanjiang, Guangdong, China
-
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
RECRUITINGShenzhen, Guangdong, China
-
Dongguan People's Hospital
RECRUITINGDongguan, Guangdong, China
-
Sun yat-sen university cancer center
RECRUITINGGuangzhou, Guangdong, 510060, China
-
The University of Hong Kong-Shenzhen Hospital
RECRUITINGShenzhen, Guangdong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a baking soda rinse tame radiation mouth sores?
- New drug duo aims to keep advanced nasopharyngeal cancer in check
- New surveillance strategy aims to catch residual cancer early in High-Risk nasopharyngeal carcinoma
- New combo strategy aims to catch and remove leftover cancer after radiation
- New combo injection targets Hard-to-Treat head and neck tumors
- New risk model may personalize Post-Chemo decisions for nasopharyngeal cancer